Bayer makes $62bn Monsanto bid

Pharmaceutical company Bayer has revealed that it is offering to buy Monsanto for $62 billion.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

Bayer completes acquisition of Monsanto

7 June 2018 German life sciences company Bayer has completed the $66 billion buyout of agricultural corporation Monsanto, a week after the US government announced Bayer must divest $9 billion worth of assets for the deal to proceed.

Americas

DowDuPont unit and Monsanto sign insect licensing deal

23 May 2018 Corteva Agriscience, the agriculture division of DowDuPont, has signed a licensing deal with Monsanto to use its technology for fighting insects found on corn.

Big Pharma

European Commission clears Bayer’s $62.5bn Monsanto buy

22 March 2018 The European Commission has approved Bayer’s $62.5 billion acquisition of agrochemical company Monsanto, subject to conditions.

More on this story

Americas

Bayer completes acquisition of Monsanto

Americas

DowDuPont unit and Monsanto sign insect licensing deal

23 May 2018 Corteva Agriscience, the agriculture division of DowDuPont, has signed a licensing deal with Monsanto to use its technology for fighting insects found on corn.

Big Pharma

European Commission clears Bayer’s $62.5bn Monsanto buy

22 March 2018 The European Commission has approved Bayer’s $62.5 billion acquisition of agrochemical company Monsanto, subject to conditions.

More on this story

Americas

Bayer completes acquisition of Monsanto

Americas

DowDuPont unit and Monsanto sign insect licensing deal

23 May 2018 Corteva Agriscience, the agriculture division of DowDuPont, has signed a licensing deal with Monsanto to use its technology for fighting insects found on corn.

Big Pharma

European Commission clears Bayer’s $62.5bn Monsanto buy

22 March 2018 The European Commission has approved Bayer’s $62.5 billion acquisition of agrochemical company Monsanto, subject to conditions.